Why does leprosy persist in Ethiopia despite elimination claims?

Question

Accepted Answer

Leprosy Persists in Ethiopia Due to Enduring Societal Stigma and Reduced International Aid

Despite Ethiopia officially declaring leprosy eliminated as a public health problem in 1999, approximately 2,500 new infections continue to be recorded annually. This persistence is largely attributed to a deeply ingrained societal stigma, where the disease is often misunderstood and perceived as divine punishment, coupled with significant recent cuts in international aid that threaten existing control efforts.
Societal Misinformation and Stigma Perpetuate the Disease

Leprosy, caused by the bacterium Mycobacterium leprae, affects the skin and peripheral nerves and can lead to physical deformities. In Ethiopia, a country with strong religious traditions, this condition is frequently viewed not as a curable illness but as a consequence of divine retribution. This perception is exacerbated by a general lack of public information regarding the disease, leading to widespread misunderstanding and a persistent stigma. This societal attitude results in the disgust and avoidance of affected individuals, as exemplified by Tilahun Wale, who lost his family after contracting leprosy, and Haile Kairos, who faces similar discrimination.
Historical Context of Isolation and Evolving Perceptions

The historical context of leprosy in Ethiopia is marked by isolation, with institutions like the Alert Hospital in Addis Ababa originally established as leper colonies in 1934, situated far from residential areas. While the capital city has since expanded to encompass the hospital, the legacy of separating those affected by the disease lingers. Although organizations like the International Leprosy Mission are working to raise awareness and provide support, and some patients, like 70-year-old Atale Mekuriyaw, report a diminished stigma and improved social integration due to medication access, the deeply rooted societal beliefs are slow to change.
Reduced International Funding Jeopardises Control Efforts

The World Health Organisation (WHO) has acknowledged Ethiopia's progress in leprosy treatment and care. However, recent substantial reductions in financial aid from key Western countries, including a significant budget cut by the WHO itself following the withdrawal of its largest donor, pose a serious threat to ongoing initiatives. This reduction in funding directly impacts the availability of crucial preventative medicines, which have historically been supplied by the WHO to facilities such as Alert Hospital.
Uncertain Future for Leprosy Eradication Without Sustained Support

The Ethiopian authorities have reportedly pledged a "backup plan" to continue treatment and eradication efforts. Nevertheless, the director of Alert Hospital, Shimelis Gezahegn, has indicated that significant challenges and potential problems are anticipated due to the funding shortfalls. The long-term success of Ethiopia's fight against leprosy hinges on the government's ability to fill the void left by reduced international aid and to further combat the pervasive societal stigma through comprehensive public health education.

Reading history

Hide →

This history is cleared when the page is closed.

Why does leprosy persist in Ethiopia despite elimination claims?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends